https://www.selleckchem.com/products/erastin.html
tral valve interventions. Earlier we reported 3-month graft patency and clinical outcomes of prospective randomized comparison of off-pump and on-pump multivessel coronary artery bypass surgery to evaluate outcomes and graft patency (PROMOTE patency) trial. We now report major adverse cardiac and cerebrovascular events (MACCE) at 1year of patients who underwent coronary artery bypass grafting (CABG) using either off-pump technique or on-pump technique. The PROMOTE patency trial is a two-arm, prospective, randomized, multicentre trial, a
Like
Comment
Share
